CVE detail

CVE-2021-23877 — CVE-2021-23877

Published 2021-10-26 · Modified 2026-06-17 · Vendor mcafee · Product total_protection · Source nvd

MEDIUM

severity

CVSS-derived band

6.7

CVSS v3

0–10 scale

0.0036

EPSS probability

exploitation probability, 30d

29.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

Privilege escalation vulnerability in the Windows trial installer of McAfee Total Protection (MTP) prior to 16.0.34_x may allow a local user to run arbitrary code as the admin user by replacing a specific temporary file created during the installation of the trial version of MTP.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.